enVVeno Medical Corp (NVNO) reporting calendar
enVVeno Medical Corp files periodic reports with the SEC as NVNO on Nasdaq. Atlas tracks 32 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 4 Jul 2026 – 27 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 6 May 2026
- Reports on record
- 32
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 31 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open NVNO market profile
Latest filing on SEC EDGAR ↗
Surgical & Medical Instruments & Apparatus reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 6 May 2026 | 36 days | 0001493152-26-021490 |
| 10-K | 31 Dec 2025 | 26 Mar 2026 | 85 days | 0001493152-26-012928 |
| 10-Q | 30 Sep 2025 | 30 Oct 2025 | 30 days | 0001493152-25-020215 |
| 10-Q | 30 Jun 2025 | 31 Jul 2025 | 31 days | 0001493152-25-011521 |
| 10-Q | 31 Mar 2025 | 30 Apr 2025 | 30 days | 0001641172-25-007908 |
| 10-K | 31 Dec 2024 | 28 Feb 2025 | 59 days | 0001493152-25-008581 |
| 10-Q | 30 Sep 2024 | 31 Oct 2024 | 31 days | 0001493152-24-043100 |
| 10-Q | 30 Jun 2024 | 31 Jul 2024 | 31 days | 0001493152-24-029737 |
| 10-Q | 31 Mar 2024 | 8 May 2024 | 38 days | 0001493152-24-018225 |
| 10-K | 31 Dec 2023 | 29 Feb 2024 | 60 days | 0001493152-24-008336 |
| 10-Q | 30 Sep 2023 | 26 Oct 2023 | 26 days | 0001493152-23-038302 |
| 10-Q | 30 Jun 2023 | 31 Jul 2023 | 31 days | 0001493152-23-026085 |
| 10-Q | 31 Mar 2023 | 28 Apr 2023 | 28 days | 0001493152-23-014683 |
| 10-K | 31 Dec 2022 | 2 Mar 2023 | 61 days | 0001493152-23-006587 |
| 10-Q | 30 Sep 2022 | 27 Oct 2022 | 27 days | 0001493152-22-029717 |
| 10-Q | 30 Jun 2022 | 3 Aug 2022 | 34 days | 0001493152-22-021166 |
| 10-Q | 31 Mar 2022 | 29 Apr 2022 | 29 days | 0001493152-22-011591 |
| 10-K | 31 Dec 2021 | 28 Mar 2022 | 87 days | 0001493152-22-007802 |
| 10-Q | 30 Sep 2021 | 12 Nov 2021 | 43 days | 0001493152-21-027916 |
| 10-Q | 30 Jun 2021 | 11 Aug 2021 | 42 days | 0001493152-21-019224 |
| 10-Q | 31 Mar 2021 | 12 May 2021 | 42 days | 0001493152-21-011110 |
| 10-K | 31 Dec 2020 | 31 Mar 2021 | 90 days | 0001493152-21-007526 |
| 10-Q | 30 Sep 2020 | 17 Nov 2020 | 48 days | 0001493152-20-021849 |
| 10-Q | 30 Jun 2020 | 14 Aug 2020 | 45 days | 0001493152-20-015611 |
| 10-Q | 31 Mar 2020 | 8 Jun 2020 | 69 days | 0001493152-20-010767 |
| 10-K | 31 Dec 2019 | 18 Mar 2020 | 78 days | 0001493152-20-004260 |
| 10-Q | 30 Sep 2019 | 31 Oct 2019 | 31 days | 0001493152-19-016299 |
| 10-Q | 30 Jun 2019 | 5 Aug 2019 | 36 days | 0001493152-19-011628 |
| 10-Q | 31 Mar 2019 | 9 May 2019 | 39 days | 0001493152-19-006722 |
| 10-K | 31 Dec 2018 | 14 Mar 2019 | 73 days | 0001493152-19-003283 |
| 10-Q | 30 Sep 2018 | 7 Nov 2018 | 38 days | 0001493152-18-015351 |
| 10-Q | 30 Jun 2018 | 10 Aug 2018 | 41 days | 0001493152-18-011393 |
Source: SEC EDGAR company submissions for CIK 0001661053. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.